Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.03 | 0.5 |
mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.5 |
mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |